Related Experiment Videos

Detection of JC virus DNA in peripheral lymphocytes from patients with and without progressive multifocal

C Tornatore1, J R Berger, S A Houff

  • 1Section of Molecular Virology, National Institute of Neurological Disorders and Stroke, Bethesda, MD 20892.

Annals of Neurology
|April 1, 1992
PubMed

Insights

JC virus (JCV) DNA was found in the lymphocytes of most progressive multifocal leukoencephalopathy (PML) patients, suggesting lymphocytes spread JCV to the brain. This finding aids understanding of PML pathogenesis.

Area of Science:

  • Neurovirology
  • Immunology
  • Molecular Biology

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease caused by JC virus (JCV) lytic infection of oligodendrocytes.
  • Hematogenous spread of JCV to the central nervous system is suspected, but JCV has not been clearly detected in peripheral circulation.
  • Oligodendrocytes are the myelin-producing cells in the central nervous system.

Purpose of the Study:

  • To investigate the presence of the JCV genome in peripheral lymphocytes of PML patients.
  • To determine if lymphocytes serve as a vector for JCV dissemination to the central nervous system.
  • To compare JCV detection rates in PML patients with HIV-1-seropositive and immunocompetent control groups.

Main Methods:

  • Polymerase chain reaction (PCR) was used to detect the JCV genome in peripheral lymphocytes.
  • Peripheral lymphocytes from PML patients, HIV-1-seropositive controls, and Parkinson's disease controls were analyzed.
  • Cerebrospinal fluid (CSF) from PML patients was also tested for the JCV genome.
  • Sequencing of the JCV regulatory region was performed on positive samples.

Main Results:

  • The JCV genome was detected in 89% of PML patients' lymphocytes, 38% of HIV-1-seropositive controls, and 0% of Parkinson's disease controls.
  • Different JCV strains (MAD-1, MAD-4) were identified in PML patients and one HIV-1-positive patient.
  • Only 30% of PML patients with JCV in lymphocytes also had JCV detected in their CSF.

Conclusions:

  • The JCV genome is present in circulating lymphocytes of PML patients.
  • Peripheral lymphocytes are likely a significant vector for the hematogenous dissemination of JCV to the central nervous system.
  • Detection of JCV in lymphocytes offers a potential diagnostic marker and insight into PML pathogenesis.

Related Concept Videos